AI Verdict
RLI has stronger fundamentals based on our AI analysis.
RLMD vs RLI Fundamental Comparison
| Metric | RLMD | RLI |
|---|---|---|
| Revenue | $5.2M | $1.9B |
| Net Income | $-57.4M | $403.3M |
| Net Margin | -1,113.9% | 21.4% |
| ROE | -66.3% | 22.7% |
| ROA | -61.0% | 6.5% |
| Current Ratio | 14.62x | N/A |
| Debt/Equity | 0.00x | 0.06x |
| EPS | $-1.45 | $4.37 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLMD vs RLI: Frequently Asked Questions
Is RLMD or RLI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLI has stronger fundamentals. RLMD is rated STRONG SELL (78% confidence) while RLI is rated BUY (72% confidence). This is not investment advice.
How does RLMD compare to RLI fundamentally?
RELMADA THERAPEUTICS, INC. has ROE of -66.3% vs RLI CORP's 22.7%. Net margins are -1,113.9% vs 21.4% respectively.
Which stock pays higher dividends, RLMD or RLI?
RLMD has a dividend yield of N/A or no dividend while RLI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLMD or RLI for long term?
For long-term investing, consider that RLMD has STRONG SELL rating with 78% confidence, while RLI has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLMD vs RLI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLMD vs RLI, the AI consensus favors RLI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.